quinupristin/dalfopristin will enhance the degree or influence of lemborexant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Steer clear of coadministration of lemborexant with average or potent CYP3A inhibitors. quinupristin/dalfopristin will enhance the